10,13-Dimethyl-1,6,7,8,9,10,11,12,13,14,15,16-dodecahydro-2H-cyclopenta[a]phenanthrene-3,17-dione (Metabolite)

Pubchem:PUBCHEM:6128

Id:57c7666e-8620-5545-9aff-90b3a7d1b444

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View 10,13-Dimethyl-1,6,7,8,9,10,11,12,13,14,15,16-dodecahydro-2H-cyclopenta[a]phenanthrene-3,17-dione's neighborhood in the knowledge graph.

Submit

Results found

Linked to

	Label	Description
	10,13-Dimethyl-1,6,7,8,9,10,11,12,13,14,15,16-dodecahydro-2H-cyclopenta[a]phenanthrene-3,17-dione correlated with condition Schizophrenia Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from Metabolomics
	10,13-Dimethyl-1,6,7,8,9,10,11,12,13,14,15,16-dodecahydro-2H-cyclopenta[a]phenanthrene-3,17-dione correlated with condition Polycystic Ovary Syndrome Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from Metabolomics
	SRD5A2 causally influences 10,13-Dimethyl-1,6,7,8,9,10,11,12,13,14,15,16-dodecahydro-2H-cyclopenta[a]phenanthrene-3,17-dione Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from Metabolomics
	Adrenal Glands produces 10,13-Dimethyl-1,6,7,8,9,10,11,12,13,14,15,16-dodecahydro-2H-cyclopenta[a]phenanthrene-3,17-dione Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from Metabolomics
	Urine produces 10,13-Dimethyl-1,6,7,8,9,10,11,12,13,14,15,16-dodecahydro-2H-cyclopenta[a]phenanthrene-3,17-dione Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from Metabolomics
	HSD3B1 causally influences 10,13-Dimethyl-1,6,7,8,9,10,11,12,13,14,15,16-dodecahydro-2H-cyclopenta[a]phenanthrene-3,17-dione Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from Metabolomics
	CYP19A1 causally influences 10,13-Dimethyl-1,6,7,8,9,10,11,12,13,14,15,16-dodecahydro-2H-cyclopenta[a]phenanthrene-3,17-dione Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from Metabolomics
	CYP11B1 causally influences 10,13-Dimethyl-1,6,7,8,9,10,11,12,13,14,15,16-dodecahydro-2H-cyclopenta[a]phenanthrene-3,17-dione Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from Metabolomics
	CYP11B2 causally influences 10,13-Dimethyl-1,6,7,8,9,10,11,12,13,14,15,16-dodecahydro-2H-cyclopenta[a]phenanthrene-3,17-dione Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from Metabolomics
	Amniotic Fluid produces 10,13-Dimethyl-1,6,7,8,9,10,11,12,13,14,15,16-dodecahydro-2H-cyclopenta[a]phenanthrene-3,17-dione Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from Metabolomics

10,13-Dimethyl-1,6,7,8,9,10,11,12,13,14,15,16-dodecahydro-2H-cyclopenta[a]phenanthrene-3,17-dione correlated with condition Schizophrenia

Knowledge Graph Assertion (Entity type)